Skip to main content
NTRA
NASDAQ Life Sciences

Natera Slides 15% as Wider-Than-Expected Q3 Loss Overshadows Revenue Beat and Raised Outlook

Tom Rudovsky · Reported by Benzinga
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$316.02
Mkt Cap
$45.552B
52W Low
$181
52W High
$437.408
52W Position info
75% above low
Off High info
28% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

NTRA sits 75% above its 52-week low of $181 on elevated volume (1.8× avg).

Summary

Natera delivered a big top-line beat — Q3 revenue of $793.98 million versus the $704.90 million consensus, up 34.08% year over year — and raised full-year 2026 revenue guidance to $3.01-$3.04 billion from $2.85-$2.91 billion, a $140 million lift at the midpoint. The problem is the bottom line: the loss of 42 cents a share was wider than the 29-cent loss analysts expected, even though it narrowed from 64 cents a year ago. Test volume grew 22.3% to about 1.09 million, with oncology up 60.9% to roughly 339,500 tests, and the company ended September with about $1.1 billion in cash. Shares were down 15.49% at $307.41 Friday, a sharp reaction for a company that just beat and raised — the market is punishing the wider loss and the cost structure rather than rewarding the revenue strength. This follows the prior evening's Q3 release and the simultaneous announcement that Solomon Moshkevich is taking over as CEO from Steve Chapman, so investors are digesting a new chief executive alongside the margin miss.

At the time of this announcement, NTRA was trading at $316.02 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $45.6B. The 52-week trading range was $181.00 to $437.41. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

NTRA - Latest Insights

NTRA
Nov 05, 2026, 4:49 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $293.97
Real-time Price: $314.47 info
Change: +$20.50 (+7%) info
Market Cap: $45.362B info
NTRA
Nov 05, 2026, 4:06 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $366.75
Real-time Price: $314.47 info
Change: -$52.28 (-14%) info
Market Cap: $45.362B info
NTRA
Nov 05, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $363.76
Real-time Price: $314.47 info
Change: -$49.29 (-14%) info
Market Cap: $45.362B info
NTRA
Nov 03, 2026, 7:00 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $380.77
Real-time Price: $314.47 info
Change: -$66.30 (-17%) info
Market Cap: $45.362B info
NTRA
Oct 09, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $391.54
Real-time Price: $314.47 info
Change: -$77.07 (-20%) info
Market Cap: $45.362B info